Identification of critical prognosis signature associated with lymph node metastasis of stomach adenocarcinomas

World Journal of Surgical Oncology

Research

Yulin Guo¹  Xiaohui Wang¹  Yifei Zhang¹  Wei Zhang¹  Yibin Xie²  Xiaofeng Bai² 

[1] Department of General Surgery, Xuanwu Hospital, Capital Medical University, 100053, Beijing, China;Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100021, Beijing, China;

关键词: Data mining;    Prognosis;    Biological maker;    Expression difference;    Functional enrichment analysis;   

DOI  :  10.1186/s12957-023-02940-y

 received in 2022-10-13, accepted in 2023-02-11,  发布年份 2023

来源: Springer

【 摘 要 】

Lymph node metastasis (LNM) is an important factor affecting the prognosis of patients with gastric adenocarcinoma (STAD), which is the most common malignancy of the human digestive system. Current detection techniques have limited sensitivity and specificity, and there is a lack of effective biomarkers to screen for LNM. Therefore, it is critical to screen for biomarkers that predict LNM in STAD. Gene expression differential analysis (false discovery rate < 0.05, |log2Fold change| ≥1.5) was performed on 102 LNM samples, 224 non-LNM samples, and 29 normal gastric tissue samples from The Cancer Genome Atlas (TCGA) STAD dataset, and 269 LNM-specific genes (DEGs) were obtained. Enrichment analysis showed that LNM-specific genes functioned mainly in cytokine-cytokine receptor interactions, calcium signaling, and other pathways. Ten DEGs significantly associated with overall survival in STAD patients were screened by multivariate Cox regression, and an LNM-based 10-mRNA prognostic signature was established (Logrank P < 0.0001). This 10-mRNA signature was well predicted in both the TCGA training set and the Gene Expression Omnibus validation dataset (GSE84437) and was associated with survival in patients with LNM or advanced-stage STAD. Using Kaplan-Meier survival, receiver operating characteristic curve, C-index analysis, and decision curve analysis, the 10-mRNA signature was found to be a more effective predictor of prognosis in STAD patients than the other two reported models (P < 0.0005). Protein-protein interaction network and gene set enrichment analysis of the 10-mRNA signature revealed that the signature may affect the expression of multiple biological pathways and related genes. Finally, the expression levels of prognostic genes in STAD tissues and cell lines were verified using qRT-PCR, Western blot, and the Human Protein Atlas database. Taken together, the prognostic signature constructed in this study may become an indicator for clinical prognostic assessment of LNM-STAD and provide a new strategy for future targeted therapy.

【 授权许可】

CC BY   
© The Author(s) 2023

【 图 表 】

Fig. 4

Fig. 2

40854_2023_458_Article_IEq23.gif

Fig. 2

Fig. 6

Fig. 2

Fig. 3

Fig. 5

Fig. 2

Fig. 2

12302_2023_718_Article_IEq50.gif

12888_2023_4583_Article_IEq3.gif

Fig. 2

Fig. 6

Fig. 5

Fig. 3

Fig. 5

Fig. 2

40517_2023_248_Article_IEq34.gif